title: Continued Role of Splenectomy in the Management of Patients With Myelofibrosis.
authors.affiliation: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: Daniel
authors.initials: D
authors.lastname: Aruch
authors.affiliation: Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: Myron
authors.initials: M
authors.lastname: Schwartz
authors.affiliation: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: John
authors.initials: J
authors.lastname: Mascarenhas
authors.affiliation: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: Marina
authors.initials: M
authors.lastname: Kremyanskaya
authors.affiliation: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
authors.forename: Carrie
authors.initials: C
authors.lastname: Newsom
authors.affiliation: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: aruchd13@yahoo.com.
authors.forename: Ronald
authors.initials: R
authors.lastname: Hoffman
mesh_terms: D000368:Aged; D015331:Cohort Studies; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D055728:Primary Myelofibrosis / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery*; D013156:Splenectomy / Q000706:statistics & numerical data
keywords: Cytopenias; JAK2 inhibition; Myeloproliferative neoplasms; Ruxolitinib; Splenomegaly